<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04204512</url>
  </required_header>
  <id_info>
    <org_study_id>ECHORTON (29BRC19.0275)</org_study_id>
    <nct_id>NCT04204512</nct_id>
  </id_info>
  <brief_title>Comparison of 22Mhz and 18Mhz High-frequency Probes for the Ultrasound Study of Temporal Arteries in Patients Suspected of Having Giant Cell Arteritis</brief_title>
  <acronym>ECHORTON</acronym>
  <official_title>Comparison of 2 Probes Frequencies in the Diagnosis of Giant Cell Arteritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of the structural features of temporal arteritis using two frequencies probes: 18
      and 22Mhz.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Comparison of the results obtained by using 2 different frequencies probes in the diagnosis
      of giant cell arteritis
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 17, 2019</start_date>
  <completion_date type="Anticipated">June 17, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 17, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>halo sign of temporal arteritis</measure>
    <time_frame>inclusion</time_frame>
    <description>hypoechogenicity of the wall artery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>compression sign of of temporal arteritis</measure>
    <time_frame>inclusion</time_frame>
    <description>persistent of increased inflammatory arteries wall</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>halo sign of carotid arteritis</measure>
    <time_frame>inclusion</time_frame>
    <description>hypoechogenicity of the wall artery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>halo sign of subclavian arteritis</measure>
    <time_frame>inclusion</time_frame>
    <description>hypoechogenicity of the wall artery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>halo sign of axillary arteritis</measure>
    <time_frame>inclusion</time_frame>
    <description>hypoechogenicity of the wall artery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>other structural abnormalities in unilateral B mode</measure>
    <time_frame>inclusion</time_frame>
    <description>stenosis, occlusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>other structural abnormalities in bilateral B mode</measure>
    <time_frame>inclusion</time_frame>
    <description>stenosis, occlusion</description>
  </secondary_outcome>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Giant Cell Arteritis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        patients with suspicion of giant cell arteritis
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  sedimentation rate&gt; 50 mm/h or recent unusual headache or unusual fever, recent visual
             trouble or jaw claudication, or induration temporal arteritis

        Exclusion Criteria:

          -  previous diagnosis of giant cell arteritis and relapse of the giant cell arteritis and
             opposition to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sandrine Jousse-joulin</last_name>
    <phone>02-98-38-22-30</phone>
    <email>sandrine.jousse@chu-brest.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHRU de Brest</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandrine JOUSSE-JOULIN</last_name>
      <phone>02-98-38-22-30</phone>
      <email>sandrine.jousse@chu-brest.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>December 17, 2019</study_first_submitted>
  <study_first_submitted_qc>December 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 19, 2019</study_first_posted>
  <last_update_submitted>February 8, 2020</last_update_submitted>
  <last_update_submitted_qc>February 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ultrasound,</keyword>
  <keyword>giant cell arteritis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polymyalgia Rheumatica</mesh_term>
    <mesh_term>Giant Cell Arteritis</mesh_term>
    <mesh_term>Arteritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All collected data that underlie results in a publication</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>Data will be available beginning 18 month and ending five years following the end of study</ipd_time_frame>
    <ipd_access_criteria>Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

